ARTICLE | Company News
Chemokine Therapeutics cancer news
September 29, 2008 7:00 AM UTC
Chemokine hired Denmar Dixon to evaluate strategic alternatives. The company's CTCE-9908, a peptide analog of the chemokine SDF-1 and CXCR4 antagonist, is slated to begin Phase II testing to treat l...